NCT01469052 2012-03-26First In Human, Phase 1 Study of AG013736 In Patients With Solid TumorsPfizerPhase 1 Completed36 enrolled 16 charts
NCT00949624 2012-01-19CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid TumorsArog Pharmaceuticals, Inc.Phase 1 Completed50 enrolled